Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Lymphoma, Large B-Cell, Diffuse 14Multiple Myeloma 12Leukemia, Myeloid, Acute 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Non-Hodgkin 8Lymphoma, Mantle-Cell 8Lymphoma, Follicular 8Leukemia, Lymphocytic, Chronic, B-Cell 8Glioblastoma 7Lymphoma, B-Cell 6Burkitt Lymphoma 6Prostatic Neoplasms 5Recurrence 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma 4Hematologic Neoplasms 4Breast Neoplasms 4Triple Negative Breast Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Melanoma 3Hodgkin Disease 3Glioma 3Astrocytoma 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Sarcoma, Synovial 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Mycosis Fungoides 2

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Recurrence × Leukapheresis × Clear all
NCT02431988 2023-04-28

COBALT

University College, London

Phase 1 Completed
10 enrolled
Lymphoid

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02761915 2021-08-17

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

Cancer Research UK

Phase 1 Completed
17 enrolled 17 charts
CNS

Cytokine Release Syndrome, Neuroblastoma, Recurrence

NCT03126864 2019-11-04

Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia

M.D. Anderson Cancer Center

Phase 1 Terminated
11 enrolled
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT00089453 2012-04-19

Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

University of Arkansas

Phase 1 Completed
10 enrolled
Plasma cell

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡